Fast Five Quiz: Atrial Fibrillation and Diabetes

Sandeep K. Goyal, MD


April 02, 2020

The decision of whether or not to place a patient with AF on anticoagulation therapy should be based on their individual estimated risk for thromboembolism using the CHA2DS2-VASc score for stroke-risk assessment, which includes DM as a risk factor.

Although consideration of patient adherence is important in treatment decisions, not all patients with AF require anticoagulation. In a recent study of patients with DM and AF, the duration of diabetes was more important than glycemic control in predicting stroke risk. Although electrical cardioversion is highly effective in the acute care setting, patients often revert to AF within 1 year. Chemical cardioversion has not been well-studied in patients with DM.

Learn more about the atrial fibrillation CHA2DS2-VASc score calculator.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.